NMR screening in fragment-based drug design: a practical guide

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Biophysics

Background:

• Fragment-based drug design (FBDD) is a key strategy for discovering novel drug candidates.
• Fragment hits typically exhibit lower molecular weight and initial potency but higher ligand efficiency compared to high-throughput screening hits.
• Nuclear Magnetic Resonance (NMR) spectroscopy is crucial for identifying and localizing the binding of weakly interacting fragments to target proteins.

Purpose of the Study:

• To present ligand-based NMR methods for hit identification within fragment libraries.
• To describe the functional cross-validation of primary fragment hits using NMR.

Main Methods:

• Utilizing NMR spectroscopy for fragment-based screening (FBS).
• Applying ligand-based NMR techniques for hit identification.
• Performing functional cross-validation of identified fragment hits.

Main Results:

• Successful identification of initial fragment hits from libraries using NMR.
• Demonstration of NMR's capability to localize fragment binding sites.
• Validation of primary hits through functional cross-validation assays.

Conclusions:

• Ligand-based NMR methods are effective for hit identification in FBDD.
• NMR spectroscopy plays a vital role in both initial hit discovery and subsequent validation within FBDD.
• This approach facilitates the efficient elaboration of fragment hits into lead compounds.